Organogenesis Achieves Primary Endpoint in Randomized Controlled Trial of PuraPly®AM

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/27/2026

1. SPY
2. AKAM
3. COST
4. META
5. ZS
6. NVDA
7. ULS
8. AWK
9. DRI
10. USO

Go back to Organogenesis Achieves Primary Endpoint in Randomized Controlled Trial of PuraPly®AM
(NASDAQ: ORGO) Delayed: 1.41 -0.01 (0.7%)
Previous Close $1.42    52 Week High $ 
Open $1.43    52 Week Low $ 
Day High $1.44    P/E N/A 
Day Low $1.36    EPS $ 
Volume 609,301